Home Healthcare Healthcare Services ADME Toxicology Testing Market

ADME Toxicology Testing Market Size, Share & Trends Analysis Report By Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology), By Testing Method (Cellular Assay, Biochemical Assay, In-Silica, Ex-vivo), By Application (Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Toxicities) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 11, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR6874DR | Pages: 160
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. ADME Toxicology Testing Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Cell Culture
    2. High Throughput
    3. Molecular Imaging
    4. OMICS Technology
  2. ADME Toxicology Testing Market, By Testing Method 2022-2034 (USD MILLION/ Units)
    1. Cellular Assay
    2. Biochemical Assay
    3. In-Silica
    4. Ex-vivo
  3. ADME Toxicology Testing Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Systemic Toxicity
    2. Renal Toxicity
    3. Hepatotoxicity
    4. Neurotoxicity
    5. Other Toxicities
  4. Regional ADME Toxicology Testing Market
    1. North America
      1. North America ADME Toxicology Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
      2. North America ADME Toxicology Testing Market By Testing Method 2022-2034 (USD MILLION/ Units)
        1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo
      3. North America ADME Toxicology Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities
      4. U.S.
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      5. Canada
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
    2. Europe
      1. Europe ADME Toxicology Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
      2. Europe ADME Toxicology Testing Market By Testing Method 2022-2034 (USD MILLION/ Units)
        1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo
      3. Europe ADME Toxicology Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities
      4. U.K.
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      5. Germany
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      6. France
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      7. Spain
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      8. Italy
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      9. Russia
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      10. Nordic
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      11. Benelux
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      12. Rest of Europe
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
    3. APAC
      1. APAC ADME Toxicology Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
      2. APAC ADME Toxicology Testing Market By Testing Method 2022-2034 (USD MILLION/ Units)
        1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo
      3. APAC ADME Toxicology Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities
      4. China
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      5. Korea
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      6. Japan
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      7. India
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      8. Australia
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      9. Taiwan
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      10. South East Asia
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      11. Rest of Asia-Pacific
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
    4. Middle East and Africa
      1. Middle East and Africa ADME Toxicology Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
      2. Middle East and Africa ADME Toxicology Testing Market By Testing Method 2022-2034 (USD MILLION/ Units)
        1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo
      3. Middle East and Africa ADME Toxicology Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities
      4. UAE
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      5. Turkey
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      6. Saudi Arabia
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      7. South Africa
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      8. Egypt
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      9. Nigeria
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      10. Rest of MEA
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
    5. LATAM
      1. LATAM ADME Toxicology Testing Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
      2. LATAM ADME Toxicology Testing Market By Testing Method 2022-2034 (USD MILLION/ Units)
        1. Cellular Assay
        2. Biochemical Assay
        3. In-Silica
        4. Ex-vivo
      3. LATAM ADME Toxicology Testing Market By Application 2022-2034 (USD MILLION/ Units)
        1. Systemic Toxicity
        2. Renal Toxicity
        3. Hepatotoxicity
        4. Neurotoxicity
        5. Other Toxicities
      4. Brazil
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      5. Mexico
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      6. Argentina
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      7. Chile
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      8. Colombia
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
      9. Rest of LATAM
        1. Cell Culture
        2. High Throughput
        3. Molecular Imaging
        4. OMICS Technology
        5. Cellular Assay
        6. Biochemical Assay
        7. In-Silica
        8. Ex-vivo
        9. Systemic Toxicity
        10. Renal Toxicity
        11. Hepatotoxicity
        12. Neurotoxicity
        13. Other Toxicities
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.